Jim Cramer’s Stock Insights on MicroStrategy Incorporated, Oscar Health, CNH Industrial N.V., B&G Foods, and Rocket Lab USA

MicroStrategy’s Latest Business Move

MicroStrategy Incorporated recently concluded the offering of its 0% convertible senior notes due 2029, raising $3 billion. This move solidifies its position as a significant player in the cryptocurrency space. However, Cramer suggests investing directly in Bitcoin for those looking to capitalize on this sector.

Oscar Health’s Recent Financial Performance

Oscar Health, led by CEO Mark Bertolini, reported a quarterly loss of 22 cents per share, slightly missing analyst estimates. Despite this, the company’s sales of $2.42 billion exceeded expectations. Cramer acknowledges Bertolini’s leadership capabilities and potential impact on the company’s future.

CNH Industrial N.V.’s Position in the Market

CNH Industrial N.V. faced challenges with worse-than-expected third-quarter results and a reduced FY24 adjusted EPS outlook. Cramer advises opting for industry leader John Deere (DE) over CNH Industrial N.V., citing a preference for best-in-class companies.

B&G Foods’ Struggles

B&G Foods, Inc. experienced disappointing third-quarter financial results and issued a lower-than-expected FY24 net sales guidance, leading Cramer to dub the company as a long-standing underperformer in the market.

Rocket Lab USA’s Uncertain Future

Rocket Lab USA, Inc. garnered attention with an analyst maintaining a Neutral rating but increasing the price target. However, Cramer remains cautious about the company’s potential trajectory, likening it to a moth drawn to a flame.

Price Action: